JARED THORLEY: Open Payments
NPI 1093065385 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$83,623 in 192 payments from 8 companies in 2025. Trend: 2023 $97,505 · 2024 $82,356 · 2025 $83,623
Travel & lodging: $28,212Speaker / faculty: $26,350Speaker / faculty: $19,188Consulting: $6,799Food & beverage: $3,075
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 79 | $44,134 |
| Eisai Inc. | 68 | $27,045 |
| Exelixis Inc. | 39 | $10,539 |
| Astellas Pharma Global Development | 1 | $1,125 |
| Janssen Scientific Affairs, LLC | 1 | $375 |
| JAZZ PHARMACEUTICALS INC. | 2 | $250 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Amgen Inc. | 1 | $31 |
Products named: RYBREVANT, Lenvima, CABOMETYX, ERLEADA, Padcev, ZIIHERA, OPDIVO, ZEPZELCA.
Industry payments across UT — which companies pay providers there.
